Inhibitors of thromboxane synthesis have also been shown to reduce the release of TNF by human macrophages. The open-labeled use of the thromboxane synthase inhibitor and receptor antagonist ...

While some of the cardiovascular effects of COX2-selective inhibitors might be caused by a prostacyclin and thromboxane imbalance, multiple opposing cardiovascular influences (particularly on ...